1 Min Read
March 8 (Reuters) - MDxHealth SA :
* Reg-SelectMDx chosen by Michigan Medicine as pre-biopsy diagnostic tool in groundbreaking us prostate cancer risk clinic Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.